Description: Sol-Gel Technologies Ltd is a clinical-stage specialty pharmaceutical company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases.
Home Page: www.sol-gel.com
SLGL Technical Analysis
7 Golda Meir Street
Ness Ziona,
7403650
Israel
Phone:
972 8 931 3433
Officers
| Name | Title |
|---|---|
| Dr. Alon Seri-Levy | Co-Founder, CEO & Director |
| Mr. Gilad Mamlok | Chief Financial Officer |
| Mr. Moshe Arkin | Exec. Chairman |
| Prof. David Avnir | Co-Founder |
| Dr. Itzik Yosef | Chief Operating Officer |
| Dr. Karine Neimann | VP of Projects & Planning and Chief Chemist |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 9.3371 |
|---|---|
| Trailing PE: | 23.3684 |
| Price-to-Book MRQ: | 2.2557 |
| Price-to-Sales TTM: | 4.2798 |
| IPO Date: | 2018-01-23 |
| Fiscal Year End: | December |
| Full Time Employees: | 53 |